Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study

Harris, Stewart B.; Yale, Jean-François; Berard, Lori; Stewart, John; Abbaszadeh, Babak; Webster-Bogaert, Susan; Gerstein, Hertzel C.
March 2014
Diabetes Care;Mar2013, Vol. 37 Issue 3, p604
Academic Journal
OBJECTIVE Diabetes self-management is universally regarded as a foundation of diabetes care. We determined whether comparable glycemic control could be achieved by self-titration versus physician titration of a once-daily bolus insulin dose in patients with type 2 diabetes who are unable to achieve optimal glycemia control with a basal insulin. RESEARCH DESIGN AND METHODS Patients with type 2 diabetes, an HbA1c level >7% (53 mmol/mol), and either nocturnal hypoglycemia episodes or an insufficient basal insulin glargine level (with or without oral agents) to achieve a fasting plasma glucose level ≤6 mmol/L (108 mg/dL) were studied. Participants all had bolus insulin glulisine added at breakfast and were allocated to either algorithm-guided patient self-titration or physician titration. The primary outcome was an HbA1c level ≤7% (53 mmol/mol) without severe hypoglycemia. RESULTS After a mean (SD) follow-up of 159.4 days (36.2 days), 28.4% of participants in the self-titration arm vs. 21.2% in the physician titration arm achieved an HbA1c level of ≤7% (53 mmol/mol) without severe hypoglycemia (between-group absolute difference 7.2%; 95% CI - 23.2 to 17.7). The lower end of this 95% confidence interval was within the predetermined noninferiority boundary of -5% (P noninferiority = 0.011). CONCLUSIONS In stable patients with type 2 diabetes who are receiving doses of basal insulin glargine who require bolus insulin, a simple bolus insulin patient-managed titration algorithm is as effective as a physician-managed algorithm.


Related Articles

  • Long-Term Intensive Treatment of Type 1 Diabetes With the Short-Acting Insulin Analog Lispro in Variable Combination With NPH Insulin at Mealtime. Lalli, Carlo; Ciofetta, Marco; Del Sindaco, Paola; Torlone, Elisabetta; Pampanelli, Simeone; Compagnucci, Pietro; Cartechini, Maria Giululia; Bartocci, Linda; Brunetti, Paolo; Bolli, Geremia B. // Diabetes Care;Mar1999, Vol. 22 Issue 3, p468 

    Presents a study which established whether the short-acting insulin analog lispro can be successfully implemented in long-term intensive insulin therapy in type 1 diabetes, and the effects on glycemic control and frequency and awareness of hypoglycemia. Research design and methods; Results;...

  • Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Complicated by Problematic Hypoglycemia. Choudhary, Pratik; Rickels, Michael R.; Senior, Peter A.; Vantyghem, Marie-Christine; Maffi, Paola; Kay, Thomas W.; Keymeulen, Bart; Nobuya Inagaki; Saudek, Frantisek; Lehmann, Roger; Hering, Bernhard J. // Diabetes Care;Jun2015, Vol. 38 Issue 6, p1016 

    Problematic hypoglycemia, defined as two or more episodes per year of severe hypoglycemia or as one episode associated with impaired awareness of hypoglycemia, extreme glycemic lability, or major fear and maladaptive behavior, is a challenge, especially for patients with long-standing type 1...

  • Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Pramming, S.; Thorsteinsson, B.; Bendtson, I.; Rønn, B.; Binder, C. // British Medical Journal (Clinical Research Edition);8/10/1985, Vol. 291 Issue 6492, p376 

    The prevalence of nocturnal biochemical hypoglycaemia--that is, blood glucose concentrations below 3 retool/1 (55 rag/100 ml)--was evaluated in a random sample of 58 insulin dependent diabetics receiving twice daily insulin. Seventeen patients had at least one blood glucose value below 3 mmol/l...

  • Patient safety and minimizing risk with insulin administration - role of insulin degludec. Aye, Myint M.; Atkin, Stephen L. // Drug, Healthcare & Patient Safety;2014, Vol. 6, p55 

    Diabetes is a lifelong condition requiring ongoing medical care and patient self-management. Exogenous insulin therapy is essential in type 1 diabetes and becomes a necessity in patients with longstanding type 2 diabetes who fail to achieve optimal control with lifestyle modification, oral...

  • New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1). Riddle, Matthew C.; Bolli, Geremia B.; Ziemen, Monika; Muehlen-Bartmer, Isabel; Bizet, Florence; Home, Philip D. // Diabetes Care;Oct2014, Vol. 37 Issue 10, p2755 

    OBJECTIVE To compare the efficacy and safety of new insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in people with type 2 diabetes on basal insulin (≥42 units/day) plus mealtime insulin. RESEARCH DESIGN AND METHODS EDITION 1 (NCT01499082) was a 6-month,...

  • Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring. Dassau, Eyal; Cameron, Fraser; Lee, Hyunjin; Bequette, B. Wayne; Zisser, Howard; Jovanovič, Lois; Chase, H. Peter; Wilson, Darrell M.; Buckingham, Bruce A.; Doyle III, Francis J. // Diabetes Care;Jun2010, Vol. 33 Issue 6, p1249 

    OBJECTIVE -- The purpose of this study was to develop an advanced algorithm that detects pending hypoglycemia and then suspends basal insulin delivery. This approach can provide a solution to the problem of nocturnal hypoglycemia, a major concern of patients with diabetes. RESEARCH DESIGN AND...

  • Overall satisfaction increased more with inhaled insulin than with subcutaneous insulin in type 1 diabetes. Bilous, Rudy // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p101 

    Comments on a study which investigated treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Outcome measures; Comparison of the effects of inhaled insulin and subcutaenous insulin injection on patients with type 1 diabetes mellitus.

  • Unnecessary insulin treatment for diabetics. Kromann, H.; Borch, E.; Gale, E.A.M. // British Medical Journal (Clinical Research Edition);11/21/1981, Vol. 283 Issue 6303, p1386 

    Investigates the unnecessary insulin treatment for diabetes. Indications for starting treatment with insulin; Classification of diabetes; Symptoms of hypogycemia.

  • Insulin therapy.  // Nursing Standard;10/18/2006, Vol. 21 Issue 6, p58 

    A quiz that tests nurses' knowledge on insulin therapy is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics